title: FDA approves glaucoma treatment.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D060433:Administration, Ophthalmic; D017277:Drug Approval; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011460:Prostaglandins F / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D009883:Ophthalmic Solutions; D011460:Prostaglandins F; C485333:tafluprost